Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-01-28
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31505
Patent
active
055978274
ABSTRACT:
A class of substituted phenylpyrimidine compounds are disclosed which are potent inhibitors of the excitatory amino acid, glutamate. Such compounds are useful in the treatment or prevention of a range of CNS disorders including cerebral ischaemic damage and epilepsy.
REFERENCES:
patent: 3940393 (1976-02-01), Greenspan et al.
patent: 3980781 (1976-09-01), Snell et al.
patent: 4005203 (1977-01-01), Stickney et al.
patent: 4005204 (1977-01-01), Stickney et al.
patent: 4006235 (1977-02-01), Stickney et al.
patent: 4535080 (1985-08-01), Audiau et al.
patent: 4542136 (1985-09-01), Carminati et al.
patent: 4613603 (1986-09-01), Biziere et al.
patent: 4624952 (1986-11-01), Biziere et al.
patent: 4725600 (1988-02-01), Takaya et al.
patent: 5136080 (1992-08-01), Miller et al.
Welt et al, AACR Abstracts, 1983, #589, "Metoprine Therapy of Advanced Sarcomas In Previously Untreated Adults", Clinical Investigations.
Magill et al, ASCO Abstracts, 1982, #C-88, "Phase II Trials of Metoprine (DDMP) in Pretreated Adults with Advanced Soft Tissue Sarcomas", Clinical Pharmacology.
Cavallito et al, "Lipid-Soluble Inhibitors of Dihydrofolate Reductase 1. Kinetics, Tissue Distribution, and Extent of Metabolism of Pyrimethamine, Metoprine, and Etoprine in the Rat, Dog, and Man", vol. 6, No. 3, pp., 329-337, Drug Metabolism and Disposition.
Currie et al, "Phase I Trial of Metoprine in Patients With Advanced Cancer", Cancer Treatment Reports, vol. 64, No. 8-9, Aug./Sep. 1980, pp. 951-956.
Duch, "Elevation of Brain Histamine Levels by Diaminopyrimidine Inhibitors of Histamine N-methyl Transferase", Biochemical Pharamacology, vol. 27, pp. 1507-1509, Pergamon Press Limited 1978, printed in Great Britain.
Duch et al, "Histamine: Elevation of Brain Levels by Inhibition of Histamine N-Methyl Transferase", Copyright 1979 by Elsevier North Holland, Inc., pp. 287-295.
Georges et al, "Structural and Electronic Properties of Anticonvulsant Drugs: Substituted 3-Tertiary-amino-6-aryl-Pyridazines,-1,2,4-Triazines and -Pyrimidines", J. Chem. Soc. Perkin Trans.II, 1989, pp. 449-455.
Hamrell, "Inhibition of Dihydrofolate Reductase and Cell Growth by Antifolates in a Methotrexate-Resistant Cell Line", Oncology 41:343-348 (1984).
Hough et al, "Inhibition of Brain Histamine Metabolism by Metoprine", Biochemical Pharmacology, vol. 35, No. 2, pp. 307-310, 1986.
Leach et al, "Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug: II. Neurochemical Studies on the Mechanism of Action", Epilepsia, 27(5):490-497, 1986.
Miller et al, "New Anticonvulsant Drugs", John Libbey & Company Ltd., 1986, pp. 165-177.
Nichol et al, "Lipid-Soluble Diaminopyrimidine Inhibitors of Dihydrofolate Reductase", Cancer Treatment Reports, vol. 61, No. 4, Jul. 1977, pp. 559-564.
Serano et al, "Evaluation of the Lipid-Soluble Diaminopyrimidines, Metoprine and Etoprine, in the Avian Sarcoma Virus Rat Glioma Model", Cancer Treatment Reports, vol. 66, No. 1, Jan. 1982, pp. 99-106.
Sternberg et al, "Phase II Evaluation of Metoprine in Advanced Pancreatic Adenocarcinoma", Cancer Treatment Reports, vol. 68, No. 7-8, Jul./Aug. 1984, pp. 1053-1054.
Tuomisto et al, "Is Histamine An Anticonvulsive Inhibitory Transmitter?", Neuropharmacology, vol. 25, No. 8, pp. 955-958, 1986.
Tuomisto et al, "Inhibition of Sound-Induced Convulsions by Metoprine in the Audiogenic Seizure Susceptible Rat", Agents and Actions, vol. 20, Mar. 4 (1987), pp. 252-254.
Zawilska et al, "Changes in the Rat Brain Histamine Content Following Metoprine and Other Histamine-Methyltransferase (HMT) Inhibitors", Pol. J. Pharmacol, Pharm., 1985, 37, pp. 821-830.
Welt et al, AACR Abstracts, 1983, #588, "Phase II Chemotherapy of Pancreatic Adenocarcinoma With Metoprine (DDMP)2,4-Diamino-5-(3'4'di-chlorophenyl)-6-methyl-pyrimidine", Clinical Investigations.
Hyde Richard M.
Leach Michael J.
Miller Alistair A.
Nobbs Malcolm S.
LandOfFree
Treatment of injury of the spinal cord or brain using 4-amino-2- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of injury of the spinal cord or brain using 4-amino-2-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of injury of the spinal cord or brain using 4-amino-2- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941681